408 related articles for article (PubMed ID: 15496457)
1. Normal biogenesis and cycling of empty synaptic vesicles in dopamine neurons of vesicular monoamine transporter 2 knockout mice.
Croft BG; Fortin GD; Corera AT; Edwards RH; Beaudet A; Trudeau LE; Fon EA
Mol Biol Cell; 2005 Jan; 16(1):306-15. PubMed ID: 15496457
[TBL] [Abstract][Full Text] [Related]
2. Vesicular monoamine and glutamate transporters select distinct synaptic vesicle recycling pathways.
Onoa B; Li H; Gagnon-Bartsch JA; Elias LA; Edwards RH
J Neurosci; 2010 Jun; 30(23):7917-27. PubMed ID: 20534840
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
4. Regulation of dopamine quantal size in midbrain and hippocampal neurons.
Pothos EN
Behav Brain Res; 2002 Mar; 130(1-2):203-7. PubMed ID: 11864736
[TBL] [Abstract][Full Text] [Related]
5. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size.
Pothos EN; Larsen KE; Krantz DE; Liu Y; Haycock JW; Setlik W; Gershon MD; Edwards RH; Sulzer D
J Neurosci; 2000 Oct; 20(19):7297-306. PubMed ID: 11007887
[TBL] [Abstract][Full Text] [Related]
6. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
[TBL] [Abstract][Full Text] [Related]
7. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.
Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
J Neurosci; 1996 Jul; 16(13):4135-45. PubMed ID: 8753875
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
[TBL] [Abstract][Full Text] [Related]
11. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.
Larsen KE; Fon EA; Hastings TG; Edwards RH; Sulzer D
J Neurosci; 2002 Oct; 22(20):8951-60. PubMed ID: 12388602
[TBL] [Abstract][Full Text] [Related]
12. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action.
Fon EA; Pothos EN; Sun BC; Killeen N; Sulzer D; Edwards RH
Neuron; 1997 Dec; 19(6):1271-83. PubMed ID: 9427250
[TBL] [Abstract][Full Text] [Related]
13. A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin, and octopamine.
Greer CL; Grygoruk A; Patton DE; Ley B; Romero-Calderon R; Chang HY; Houshyar R; Bainton RJ; Diantonio A; Krantz DE
J Neurobiol; 2005 Sep; 64(3):239-58. PubMed ID: 15849736
[TBL] [Abstract][Full Text] [Related]
14. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration.
Lu W; Wolf ME
Brain Res Mol Brain Res; 1997 Oct; 49(1-2):137-48. PubMed ID: 9387873
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
Yao J; Erickson JD; Hersh LB
Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
[TBL] [Abstract][Full Text] [Related]
16. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.
Wang YM; Gainetdinov RR; Fumagalli F; Xu F; Jones SR; Bock CB; Miller GW; Wightman RM; Caron MG
Neuron; 1997 Dec; 19(6):1285-96. PubMed ID: 9427251
[TBL] [Abstract][Full Text] [Related]
17. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release.
Persico AM; Mengual E; Moessner R; Hall FS; Revay RS; Sora I; Arellano J; DeFelipe J; Gimenez-Amaya JM; Conciatori M; Marino R; Baldi A; Cabib S; Pascucci T; Uhl GR; Murphy DL; Lesch KP; Keller F
J Neurosci; 2001 Sep; 21(17):6862-73. PubMed ID: 11517274
[TBL] [Abstract][Full Text] [Related]
18. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
Pickel VM; Chan J; Nirenberg MJ
Synapse; 2002 Aug; 45(2):113-24. PubMed ID: 12112404
[TBL] [Abstract][Full Text] [Related]
19. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters.
Boulland JL; Qureshi T; Seal RP; Rafiki A; Gundersen V; Bergersen LH; Fremeau RT; Edwards RH; Storm-Mathisen J; Chaudhry FA
J Comp Neurol; 2004 Dec; 480(3):264-80. PubMed ID: 15515175
[TBL] [Abstract][Full Text] [Related]
20. Effects of genetic depletion of monoamines on somatosensory cortical development.
Alvarez C; Vitalis T; Fon EA; Hanoun N; Hamon M; Seif I; Edwards R; Gaspar P; Cases O
Neuroscience; 2002; 115(3):753-64. PubMed ID: 12435414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
